Venus Medtech (Hangzhou) Inc. (VMTHF)
OTCMKTS
· Delayed Price · Currency is USD
0.2512
-0.0359 (-12.50%)
Apr 23, 2025, 4:00 PM EDT
Venus Medtech (Hangzhou) Employees
Venus Medtech (Hangzhou) had 691 employees as of December 31, 2024. The number of employees decreased by 174 or -20.12% compared to the previous year.
Employees
691
Change (1Y)
-174
Growth (1Y)
-20.12%
Revenue / Employee
$93,351
Profits / Employee
-$141,624
Market Cap
144.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Venus Medtech (Hangzhou) News
- 3 days ago - Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations - PRNewsWire
- 8 months ago - Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study - PRNewsWire
- 11 months ago - Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. - PRNewsWire
- 1 year ago - Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval - PRNewsWire
- 1 year ago - Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023 - PRNewsWire